Evidence map›Paper›PMID 42475550›Full record

ArticleJMIR medical informatics2026

Real-World Imaging Data: Opportunities and Challenges.

Jie Wu, Aline L de Araujo, Sean Khozin, Merel Huisman, Domenico Mastrodicasa, Martin J Willemink

Abstract read
In one paragraph

Article in JMIR medical informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jie WuSegmed, Inc, 3790 El Camino Real #810, Palo Alto, CA, 94306, United States.ORCID 0000-0003-3564-9056
Aline L de AraujoSegmed, Inc, 3790 El Camino Real #810, Palo Alto, CA, 94306, United States.ORCID 0000-0002-6009-1069
Sean KhozinProject Data Sphere, Cary, NC, United States.ORCID 0000-0003-2206-7620
Merel HuismanDepartment of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, Gelderland, The Netherlands.ORCID 0000-0003-2289-7130
Domenico MastrodicasaDepartment of Radiology, School of Medicine, University of Washington, Seattle, WA, United States.ORCID 0000-0001-8227-0757
Martin J WilleminkSegmed, Inc, 3790 El Camino Real #810, Palo Alto, CA, 94306, United States.ORCID 0000-0002-6991-6557

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unlabelled: The amount of data generated in clinical practice is increasing substantially. This has benefited the use of real-world data for real-world evidence in biomedical research. While early real-world evidence efforts focused on structured electronic health record and insurance claims data, advances in analytical methods, such as AI, are expected to further enhance the ability to obtain deeper insights from real-world data. Most recently, real-world imaging data (RWiD) has emerged as a novel and valuable resource. RWiD is enabled by improvements in imaging infrastructure, data standardization, and deidentification technologies. Medical imaging is essential at multiple stages of clinical care, ranging from screening to posttreatment assessment and surveillance. Medical imaging has become a key component of patient management, as it augments clinical decision-making across many medical specialties. RWiD is the retrospective collection of routinely gathered clinical imaging data. Using only radiology reports results in limited information compared to datasets that contain the actual images. Radiology reports primarily focus on clinical decision-making rather than research purposes. Therefore, the actual images add value to real-world datasets. However, using RWiD is challenging due to complex deidentification and harmonization, as well as requirements for file storage, file transfer, and computation. This editorial paper provides an educational overview, including the background, challenges, and opportunities of RWiD, and offers examples of RWiD applications that benefit life sciences and biopharmaceutical use cases.

Indexed as

Diagnostic ImagingHumansdata biasdata diversityimagingreal-world datareal-world evidence

Identifiers

PMID42475550
PMCPMC13384349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.